Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B. (Q40636958)
Jump to navigation
Jump to search
scientific article published on May 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B. |
scientific article published on May 1999 |
Statements
1 reference
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B. (English)
1 reference
Schröder CP
1 reference
de Vries EG
1 reference
Mulder NH
1 reference
Willemse PH
1 reference
Sleijfer DT
1 reference
Hospers GA
1 reference
van der Graaf WT
1 reference
1 May 1999
1 reference
1 reference
43
1 reference
5
1 reference
741-743
1 reference
Identifiers
1 reference
1 reference